Karen Zaderej, CEO, Director at AxoGen, holds 16.50K shares in EyePoint Pharmaceuticals (Ticker: EYPT), holds 1.14M shares in AxoGen (Ticker: AXGN), holds 62.35K shares in Viveve Medical (Ticker: VIVE). Most recently, Karen Zaderej Bought ― shares of EyePoint Pharmaceuticals on Aug 21, 2024 for an estimated value of 99.75K.
What is the percentage of profitable transactions made by Karen Zaderej?
The percentage of profitable transactions made by Karen Zaderej is 89%.
What is the average return per transaction made by Karen Zaderej?
The average return per transaction made by Karen Zaderej is 36.30%.
What stocks does Karen Zaderej hold?
Karen Zaderej holds: AXGN, VIVE, EYPT stocks.
What was Karen Zaderej’s latest transaction?
Karen Zaderej latest transaction was an Informative Buy of $99.75K.
What was Karen Zaderej's most profitable transaction?
Karen Zaderej’s most profitable transaction was an Informative Buy of AXGN stock on October 14, 2016. The return on the trade was 122.40%.
What is Karen Zaderej's role in AxoGen?
Karen Zaderej's role in AxoGen is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.